Ricardo Dolmetsch
Consultant / Advisor en Trialspark, Inc. .
Fortuna: 849 701 $ al 31/03/2024
Perfil
Ricardo Dolmetsch is currently an advisor at Formation Bio Inc. He previously worked as a Senior Director at The Allen Institute for Brain Science and as the Global Head-Neuroscience at Novartis Institutes for Biomedical Research, Inc. He will be the President & Chief Scientific Officer at uniQure NV from 2020 to 2023.
He also worked as a Professor at Stanford University School of Medicine.
Dolmetsch received his undergraduate degree from Brown University and his doctorate from Stanford University.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
UNIQURE N.V.
0.34% | 18/09/2023 | 163 404 ( 0.34% ) | 849 701 $ | 31/03/2024 |
Cargos activos de Ricardo Dolmetsch
Empresas | Cargo | Inicio |
---|---|---|
Trialspark, Inc.
Trialspark, Inc. Investment ManagersFinance Trialspark, Inc(Trialspark) is a Private Equity firm founded in 2013 by Benjamine Liu, Kit Dobyns, and Linhao Zhang. The firm is headquartered in New York, US. | Consultant / Advisor | - |
Antiguos cargos conocidos de Ricardo Dolmetsch.
Empresas | Cargo | Fin |
---|---|---|
UNIQURE N.V. | President | 05/10/2023 |
The Allen Institute for Brain Science
The Allen Institute for Brain Science Miscellaneous Commercial ServicesCommercial Services The Allen Institute for Brain Science operates as a bioscience research organization, dedicated to accelerating research globally and sharing that data within the science community. The company was founded by Paul Gardner Allen and Jody Allen Patton in 2003 and is headquartered in Seattle, WA. | Director/Board Member | - |
Stanford University School of Medicine | Corporate Officer/Principal | - |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formación de Ricardo Dolmetsch.
Brown University | Undergraduate Degree |
Stanford University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
UNIQURE N.V. | Health Technology |
Empresas privadas | 3 |
---|---|
The Allen Institute for Brain Science
The Allen Institute for Brain Science Miscellaneous Commercial ServicesCommercial Services The Allen Institute for Brain Science operates as a bioscience research organization, dedicated to accelerating research globally and sharing that data within the science community. The company was founded by Paul Gardner Allen and Jody Allen Patton in 2003 and is headquartered in Seattle, WA. | Commercial Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
Trialspark, Inc.
Trialspark, Inc. Investment ManagersFinance Trialspark, Inc(Trialspark) is a Private Equity firm founded in 2013 by Benjamine Liu, Kit Dobyns, and Linhao Zhang. The firm is headquartered in New York, US. | Finance |
- Bolsa de valores
- Insiders
- Ricardo Dolmetsch